Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
thiotepa (2017)
begelomab (1 trial)
allogeneic stem cells (1 trial)
fludarabine (fludara) (1 trial)
naltrexone (revia) (1 trial)
thiotepa (1 trial)
Graft vs Host Disease (Phase 3)
Lymphoma (Phase 2)
Trials (2 total)
Trial APIs (5 total)